Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.10
STJ's Cash to Debt is ranked lower than
92% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. STJ: 0.10 )
Ranked among companies with meaningful Cash to Debt only.
STJ' s Cash to Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.35 Max: No Debt
Current: 0.1
Equity to Asset 0.31
STJ's Equity to Asset is ranked lower than
87% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. STJ: 0.31 )
Ranked among companies with meaningful Equity to Asset only.
STJ' s Equity to Asset Range Over the Past 10 Years
Min: 0.36  Med: 0.57 Max: 0.83
Current: 0.31
0.36
0.83
Interest Coverage 12.12
STJ's Interest Coverage is ranked lower than
83% of the 162 Companies
in the Global Medical Devices industry.

( Industry Median: 481.81 vs. STJ: 12.12 )
Ranked among companies with meaningful Interest Coverage only.
STJ' s Interest Coverage Range Over the Past 10 Years
Min: 9.03  Med: 15.93 Max: 24.41
Current: 12.12
9.03
24.41
F-Score: 5
Z-Score: 2.87
M-Score: -2.77
WACC vs ROIC
9.05%
13.55%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 18.59
STJ's Operating margin (%) is ranked higher than
87% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.89 vs. STJ: 18.59 )
Ranked among companies with meaningful Operating margin (%) only.
STJ' s Operating margin (%) Range Over the Past 10 Years
Min: 15.01  Med: 20.74 Max: 24.73
Current: 18.59
15.01
24.73
Net-margin (%) 15.88
STJ's Net-margin (%) is ranked higher than
85% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 0.95 vs. STJ: 15.88 )
Ranked among companies with meaningful Net-margin (%) only.
STJ' s Net-margin (%) Range Over the Past 10 Years
Min: 8.09  Med: 14.76 Max: 17.82
Current: 15.88
8.09
17.82
ROE (%) 22.09
STJ's ROE (%) is ranked higher than
92% of the 286 Companies
in the Global Medical Devices industry.

( Industry Median: 2.05 vs. STJ: 22.09 )
Ranked among companies with meaningful ROE (%) only.
STJ' s ROE (%) Range Over the Past 10 Years
Min: 11.45  Med: 18.71 Max: 23.77
Current: 22.09
11.45
23.77
ROA (%) 8.23
STJ's ROA (%) is ranked higher than
80% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: -0.07 vs. STJ: 8.23 )
Ranked among companies with meaningful ROA (%) only.
STJ' s ROA (%) Range Over the Past 10 Years
Min: 6.39  Med: 9.78 Max: 12.8
Current: 8.23
6.39
12.8
ROC (Joel Greenblatt) (%) 37.70
STJ's ROC (Joel Greenblatt) (%) is ranked higher than
84% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 3.57 vs. STJ: 37.70 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
STJ' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 33.49  Med: 44.32 Max: 58.82
Current: 37.7
33.49
58.82
Revenue Growth (3Y)(%) 4.20
STJ's Revenue Growth (3Y)(%) is ranked higher than
55% of the 209 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. STJ: 4.20 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
STJ' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -6.7  Med: 12.30 Max: 21
Current: 4.2
-6.7
21
EBITDA Growth (3Y)(%) 6.10
STJ's EBITDA Growth (3Y)(%) is ranked higher than
56% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: 2.60 vs. STJ: 6.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
STJ' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -4.6  Med: 15.05 Max: 22.2
Current: 6.1
-4.6
22.2
EPS Growth (3Y)(%) 11.10
STJ's EPS Growth (3Y)(%) is ranked higher than
60% of the 187 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. STJ: 11.10 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
STJ' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -36.7  Med: 14.05 Max: 119.9
Current: 11.1
-36.7
119.9
» STJ's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

STJ Guru Trades in Q1 2015

Louis Moore Bacon 300,000 sh (New)
Paul Tudor Jones 31,757 sh (+819.96%)
Joel Greenblatt 887,213 sh (+545.36%)
Vanguard Health Care Fund 6,023,679 sh (+11.61%)
John Rogers 1,280,608 sh (+4.97%)
James Barrow 3,030,643 sh (+1.20%)
Ken Fisher 244,337 sh (+0.47%)
Mairs and Power 2,233,959 sh (+0.44%)
Mario Gabelli 12,400 sh (unchged)
Ray Dalio Sold Out
John Buckingham 111,193 sh (-0.73%)
David Dreman 28,952 sh (-4.44%)
Jeremy Grantham 1,514,727 sh (-10.64%)
Jim Simons 203,113 sh (-72.73%)
» More
Q2 2015

STJ Guru Trades in Q2 2015

John Keeley 6,310 sh (New)
Jim Simons 271,613 sh (+33.73%)
Vanguard Health Care Fund 6,123,679 sh (+1.66%)
Ken Fisher 244,647 sh (+0.13%)
John Buckingham Sold Out
John Rogers 1,277,638 sh (-0.23%)
James Barrow 2,987,693 sh (-1.42%)
Mairs and Power 2,044,623 sh (-8.48%)
Jeremy Grantham 1,325,370 sh (-12.50%)
Mario Gabelli 8,400 sh (-32.26%)
David Dreman 19,384 sh (-33.05%)
Paul Tudor Jones 11,850 sh (-62.69%)
Louis Moore Bacon 90,000 sh (-70.00%)
Joel Greenblatt 72,464 sh (-91.83%)
» More
Q3 2015

STJ Guru Trades in Q3 2015

John Hussman 70,000 sh (New)
RS Investment Management 70,900 sh (New)
Ray Dalio 55,216 sh (New)
John Keeley 7,835 sh (+24.17%)
Ken Fisher 260,791 sh (+6.60%)
John Rogers 1,323,958 sh (+3.63%)
James Barrow 2,990,096 sh (+0.08%)
Vanguard Health Care Fund 6,123,679 sh (unchged)
Mario Gabelli 8,400 sh (unchged)
Louis Moore Bacon Sold Out
Mairs and Power 2,026,648 sh (-0.88%)
Jim Simons 265,813 sh (-2.14%)
David Dreman 18,285 sh (-5.67%)
Jeremy Grantham 863,696 sh (-34.83%)
Paul Tudor Jones 6,353 sh (-46.39%)
Joel Greenblatt 9,860 sh (-86.39%)
» More
Q4 2015

STJ Guru Trades in Q4 2015

Jeff Auxier 22,019 sh (New)
Mario Gabelli 8,400 sh (unchged)
Vanguard Health Care Fund 6,123,679 sh (unchged)
John Hussman Sold Out
James Barrow 2,978,770 sh (-0.38%)
Ken Fisher 255,140 sh (-2.17%)
» More
» Details

Insider Trades

Latest Guru Trades with STJ

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 14.28
STJ's P/E(ttm) is ranked higher than
82% of the 251 Companies
in the Global Medical Devices industry.

( Industry Median: 26.20 vs. STJ: 14.28 )
Ranked among companies with meaningful P/E(ttm) only.
STJ' s P/E(ttm) Range Over the Past 10 Years
Min: 12.71  Med: 21.65 Max: 51.32
Current: 14.28
12.71
51.32
Forward P/E 11.66
STJ's Forward P/E is ranked higher than
84% of the 181 Companies
in the Global Medical Devices industry.

( Industry Median: 18.38 vs. STJ: 11.66 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 14.28
STJ's PE(NRI) is ranked higher than
80% of the 193 Companies
in the Global Medical Devices industry.

( Industry Median: 27.11 vs. STJ: 14.28 )
Ranked among companies with meaningful PE(NRI) only.
STJ' s PE(NRI) Range Over the Past 10 Years
Min: 12.69  Med: 21.61 Max: 51.47
Current: 14.28
12.69
51.47
P/B 3.53
STJ's P/B is ranked lower than
65% of the 384 Companies
in the Global Medical Devices industry.

( Industry Median: 2.92 vs. STJ: 3.53 )
Ranked among companies with meaningful P/B only.
STJ' s P/B Range Over the Past 10 Years
Min: 2.13  Med: 4.24 Max: 6.83
Current: 3.53
2.13
6.83
P/S 2.62
STJ's P/S is ranked lower than
56% of the 383 Companies
in the Global Medical Devices industry.

( Industry Median: 2.31 vs. STJ: 2.62 )
Ranked among companies with meaningful P/S only.
STJ' s P/S Range Over the Past 10 Years
Min: 1.84  Med: 3.25 Max: 7.01
Current: 2.62
1.84
7.01
PFCF 13.49
STJ's PFCF is ranked higher than
91% of the 198 Companies
in the Global Medical Devices industry.

( Industry Median: 32.20 vs. STJ: 13.49 )
Ranked among companies with meaningful PFCF only.
STJ' s PFCF Range Over the Past 10 Years
Min: 9.89  Med: 21.17 Max: 41.61
Current: 13.49
9.89
41.61
POCF 11.53
STJ's POCF is ranked higher than
86% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: 19.76 vs. STJ: 11.53 )
Ranked among companies with meaningful POCF only.
STJ' s POCF Range Over the Past 10 Years
Min: 7.91  Med: 14.97 Max: 28.47
Current: 11.53
7.91
28.47
EV-to-EBIT 13.90
STJ's EV-to-EBIT is ranked higher than
76% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: 27.37 vs. STJ: 13.90 )
Ranked among companies with meaningful EV-to-EBIT only.
STJ' s EV-to-EBIT Range Over the Past 10 Years
Min: 10.1  Med: 19.10 Max: 34.1
Current: 13.9
10.1
34.1
EV-to-EBITDA 11.10
STJ's EV-to-EBITDA is ranked higher than
75% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: 17.32 vs. STJ: 11.10 )
Ranked among companies with meaningful EV-to-EBITDA only.
STJ' s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.5  Med: 15.10 Max: 28.1
Current: 11.1
8.5
28.1
PEG 5.00
STJ's PEG is ranked lower than
69% of the 68 Companies
in the Global Medical Devices industry.

( Industry Median: 3.33 vs. STJ: 5.00 )
Ranked among companies with meaningful PEG only.
STJ' s PEG Range Over the Past 10 Years
Min: 0.72  Med: 1.50 Max: 23.58
Current: 5
0.72
23.58
Shiller P/E 21.01
STJ's Shiller P/E is ranked higher than
87% of the 69 Companies
in the Global Medical Devices industry.

( Industry Median: 31.42 vs. STJ: 21.01 )
Ranked among companies with meaningful Shiller P/E only.
STJ' s Shiller P/E Range Over the Past 10 Years
Min: 17.31  Med: 30.78 Max: 76.25
Current: 21.01
17.31
76.25
Current Ratio 1.75
STJ's Current Ratio is ranked lower than
70% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.66 vs. STJ: 1.75 )
Ranked among companies with meaningful Current Ratio only.
STJ' s Current Ratio Range Over the Past 10 Years
Min: 1.14  Med: 2.75 Max: 4.53
Current: 1.75
1.14
4.53
Quick Ratio 1.45
STJ's Quick Ratio is ranked lower than
64% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. STJ: 1.45 )
Ranked among companies with meaningful Quick Ratio only.
STJ' s Quick Ratio Range Over the Past 10 Years
Min: 0.86  Med: 1.91 Max: 3.54
Current: 1.45
0.86
3.54
Days Inventory 173.99
STJ's Days Inventory is ranked lower than
62% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 142.23 vs. STJ: 173.99 )
Ranked among companies with meaningful Days Inventory only.
STJ' s Days Inventory Range Over the Past 10 Years
Min: 146.43  Med: 161.01 Max: 175.67
Current: 173.99
146.43
175.67
Days Sales Outstanding 81.48
STJ's Days Sales Outstanding is ranked lower than
61% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 72.25 vs. STJ: 81.48 )
Ranked among companies with meaningful Days Sales Outstanding only.
STJ' s Days Sales Outstanding Range Over the Past 10 Years
Min: 78.88  Med: 93.10 Max: 99.4
Current: 81.48
78.88
99.4
Days Payable 39.32
STJ's Days Payable is ranked lower than
70% of the 256 Companies
in the Global Medical Devices industry.

( Industry Median: 59.85 vs. STJ: 39.32 )
Ranked among companies with meaningful Days Payable only.
STJ' s Days Payable Range Over the Past 10 Years
Min: 33.34  Med: 62.70 Max: 77.56
Current: 39.32
33.34
77.56

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 2.30
STJ's Dividend Yield is ranked higher than
70% of the 189 Companies
in the Global Medical Devices industry.

( Industry Median: 1.72 vs. STJ: 2.30 )
Ranked among companies with meaningful Dividend Yield only.
STJ' s Dividend Yield Range Over the Past 10 Years
Min: 0.39  Med: 1.71 Max: 2.81
Current: 2.3
0.39
2.81
Dividend Payout 0.32
STJ's Dividend Payout is ranked higher than
54% of the 122 Companies
in the Global Medical Devices industry.

( Industry Median: 0.34 vs. STJ: 0.32 )
Ranked among companies with meaningful Dividend Payout only.
STJ' s Dividend Payout Range Over the Past 10 Years
Min: 0.28  Med: 0.32 Max: 0.63
Current: 0.32
0.28
0.63
Dividend Growth (3y) 8.70
STJ's Dividend Growth (3y) is ranked higher than
64% of the 64 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. STJ: 8.70 )
Ranked among companies with meaningful Dividend Growth (3y) only.
STJ' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 8.7
Current: 8.7
0
8.7
Forward Dividend Yield 2.30
STJ's Forward Dividend Yield is ranked higher than
68% of the 176 Companies
in the Global Medical Devices industry.

( Industry Median: 1.76 vs. STJ: 2.30 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 2.31
STJ's Yield on cost (5-Year) is ranked higher than
59% of the 189 Companies
in the Global Medical Devices industry.

( Industry Median: 1.87 vs. STJ: 2.31 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
STJ' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.39  Med: 1.71 Max: 2.81
Current: 2.31
0.39
2.81
3-Year Average Share Buyback Ratio 4.00
STJ's 3-Year Average Share Buyback Ratio is ranked higher than
97% of the 194 Companies
in the Global Medical Devices industry.

( Industry Median: -4.30 vs. STJ: 4.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
STJ' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -16.1  Med: 1.90 Max: 4.2
Current: 4
-16.1
4.2

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.13
STJ's Price/Projected FCF is ranked higher than
81% of the 217 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. STJ: 1.13 )
Ranked among companies with meaningful Price/Projected FCF only.
STJ' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.89  Med: 1.62 Max: 5.41
Current: 1.13
0.89
5.41
Price/DCF (Earnings Based) 0.85
STJ's Price/DCF (Earnings Based) is ranked higher than
85% of the 46 Companies
in the Global Medical Devices industry.

( Industry Median: 1.81 vs. STJ: 0.85 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 0.81
STJ's Price/Median PS Value is ranked higher than
69% of the 385 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. STJ: 0.81 )
Ranked among companies with meaningful Price/Median PS Value only.
STJ' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.59  Med: 1.06 Max: 2.08
Current: 0.81
0.59
2.08
Earnings Yield (Greenblatt) (%) 7.18
STJ's Earnings Yield (Greenblatt) (%) is ranked higher than
84% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 0.70 vs. STJ: 7.18 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
STJ' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 2.9  Med: 5.20 Max: 9.9
Current: 7.18
2.9
9.9
Forward Rate of Return (Yacktman) (%) 8.78
STJ's Forward Rate of Return (Yacktman) (%) is ranked higher than
61% of the 108 Companies
in the Global Medical Devices industry.

( Industry Median: 5.28 vs. STJ: 8.78 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
STJ' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 5.2  Med: 19.40 Max: 24.3
Current: 8.78
5.2
24.3

More Statistics

Revenue(Mil) $5541
EPS $ 3.52
Beta1.19
Short Percentage of Float2.24%
52-Week Range $49.30 - 80.84
Shares Outstanding(Mil)282.66

Analyst Estimate

Dec16 Dec17 Dec18
Revenue(Mil) 6,011 6,271 6,794
EPS($) 4.01 4.33 4.77
EPS without NRI($) 4.01 4.33 4.77

Latest Earnings Webcast

» More Conference Calls

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, EW » details
Traded in other countries:JUD.Germany,
St Jude Medical Inc was incorporated in Minnesota in 1976. It develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The Company's two segments are the Implantable Electronic Systems Division and the Cardiovascular and Ablation Technologies Division. The Company's principal products in each business unit are as follows: Implantable Electronic Systems Division (IESD) - tachycardia implantable cardioverter defibrillator systems (ICDs), bradycardia pacemaker systems (pacemakers) and neurostimulation products (spinal cord and deep brain stimulation devices); and Cardiovascular and Ablation Technologies Division (CATD) - vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, vascular plugs and other vascular accessories), structural heart products (heart valve replacement and repair products and structural heart defect devices) and atrial fibrillation (AF) products (electrophysiology (EP) introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems). Implantable Electronic Systems Division (IESD): IESD is focused on the cardiac rhythm management and neuromodulation therapy areas. Cardiac rhythm management devices include ICDs that provide life-saving therapy to patients suffering from lethal heart conditions, such as sudden cardiac arrest; cardiac resynchronization therapy (CRT) devices to save and improve the lives of patients suffering from heart failure (HF); pacemakers to help patients whose hearts beat too slowly or who suffer from other debilitating cardiac arrhythmias; leads (wires that connect devices to the heart) to carry electrical impulses to the heart and provide information from the heart to the device; and programmers and remote monitoring equipment which are used by physicians and healthcare professionals to program is cardiac rhythm management devices and analyze device data to improve patient management. Neuromodulation product offerings provide neurostimulation treatment in which an implantable device delivers electrical current directly to targeted nerve sites. The Company's commercialized neurostimulation therapies include spinal cord stimulation (SCS) for the treatment of chronic pain, deep brain stimulation (DBS) for treating the symptoms of Parkinson's disease and peripheral nerve stimulation (PNS) for the treatment of chronic migraine headache. A neurostimulation system typically consists of four components: a pulse generator that produces the electrical current and is implanted under the patient's skin; implanted leads that carry the electrical impulses to the targeted nerve sites; an external patient remote control that enables the patient to control his or her therapy within prescribed ranges; and an extern
» More Articles for STJ

Headlines

Articles On GuruFocus.com

More From Other Websites
St. Jude Medical upgraded by Canaccord Genuity Feb 08 2016
St. Jude Medical Announces Launch of OPTIS Mobile System in Europe and Japan Feb 08 2016
St. Jude Medical Announces Launch of OPTIS Mobile System in Europe and Japan Feb 08 2016
St. Jude Medical Announces 2016 Annual Analyst and Investor Meeting Feb 02 2016
Technical Coverage on Medical Appliances & Equipment Stocks -- St. Jude Medical, Edwards... Jan 29 2016
[$$] St. Jude Medical Hits the Reset Button Jan 29 2016
St. Jude Medical, Inc. Earnings Analysis: Q4, 2015 By the Numbers Jan 28 2016
St. Jude Medical Beats Q4 Earnings by a Penny, Misses Sales Jan 28 2016
Edited Transcript of STJ earnings conference call or presentation 27-Jan-16 1:00pm GMT Jan 27 2016
Medical device maker St. Jude 2016 forecast disappoints Jan 27 2016
[$$] St. Jude Medical Offers Weak Profit Outlook Jan 27 2016
St. Jude Medical Reports Fourth Quarter and Full-Year 2015 Results Jan 27 2016
ST JUDE MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jan 27 2016
St. Jude Medical Reports Fourth Quarter and Full-Year 2015 Results Jan 27 2016
Q4 2015 St. Jude Medical Inc Earnings Release - Before Market Open Jan 27 2016
FDA Classifies St. Jude Medical Field Action for 447 of the Company's Optisure High Voltage Leads as... Jan 22 2016
FDA Classifies St. Jude Medical Field Action for 447 of the Company's Optisure High Voltage Leads as... Jan 22 2016
St. Jude Medical (STJ) Q4 Earnings: What's in Store? Jan 22 2016
St. Jude Medical & Intuitive Surgical: Q4 Preliminary Results Jan 14 2016
Intuitive Surgical Up, St. Jude Down On Prelim Q4 Jan 13 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK